Tirzepatide users may experience gradual weight return over 6-12 months, while Qsymia discontinuation can lead to more rapid weight regain due to its shorter-acting components
Originally developed to treat type 2 diabetes, semaglutide (known under brand names like Ozempic and Wegovy) is a GLP-1 receptor agonist that helps regulate blood sugar and appetite
Conducted across 42 medical centers in the United States, this study used dual-energy X-ray absorptiometry (DXA) scanning to precisely measure body composition changes over 36 weeks of treatment
Serving Size: 2 Pumps (approximately 1 mL)
In the PIONEER 4 trial, oral semaglutide, compared with once-daily subcutaneously administered Liraglutide and placebo, showed a superior reduction in body weight when compared to both liraglutide and placebo at week 26 [31]
Overarching Principle The fundamental principle of regulation of medicines is to optimise timely access to effective treatments while reducing the risk of harm from improper use
